phase readout

NCT07524920: Comparing Efficacy and Safety of (Meropenem + Colistin) Versus (Imipenem/Cilastatin + Tigecycline) on Eradication of Multi-Drug Resistance Bacteria

NOT_YET_RECRUITINGupdated 1h ago

community read0 votes

Sponsor: Ain Shams University. Phase: PHASE2. Conditions: MDR Bacteria

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

last refreshed 1h ago

Found something off?